Literature DB >> 26986073

MiR-99a regulates ROS-mediated invasion and migration of lung adenocarcinoma cells by targeting NOX4.

Mei Sun1, Shunming Hong2, Wenhan Li2, Pengfei Wang2, Jinqiang You3, Xuebin Zhang4, Fan Tang4, Ping Wang3, Chunzhi Zhang1.   

Abstract

miR-99a is frequently downregulated in various types of human malignancies including lung adenocarcinoma. Recent studies have reported that miR-99a regulates cell growth and cell cycle progression by targeting mTOR, AKT1 and FGFR3. However, the underlying mechanisms involved in the modulation of invasion and migration by miR-99a remain elusive. In this study, we analyzed the relationship between the expression of miR-99a and clinical stage or metastasis in 90 matched lung adenocarcinoma and adjacent non-tumor lung tissues. Downregulation of miR-99a was significantly associated with advanced stage and tumor metastasis in lung adenocarcinoma patients, and it was found to be a poor prognostic factor in lung adenocarcinoma. Furthermore, functional experiments found that overexpression of miR-99a inhibited the proliferation, migration and invasion of lung adenocarcinoma A549 and Calu3 cells in vitro. We then identified NOX4 as a target gene of miR-99a and NOX4 mediated the inhibition of invasion and migration of lung adenocarcinoma cells by miR-99a. By targeting NOX4-mediated ROS production, miR-99a regulated the invasion and migration of lung adenocarcinoma cells. Moreover, overexpression of miR-99a significantly inhibited tumor growth in vivo. Immunohistochemical staining analysis of the mouse tumor tissues revealed that NOX4 levels were downregulated in the miR-99a treatment group, confirming the in vitro data of NOX4 as a direct target gene of miR-99a. Taken together, these data indicate for the first time that miR-99a directly regulates the invasion and migration in lung adenocarcinoma by targeting NOX4 and that overexpression of miR-99a may become a therapeutic strategy for lung adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26986073     DOI: 10.3892/or.2016.4672

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  14 in total

1.  TGF-β promote epithelial-mesenchymal transition via NF-κB/NOX4/ROS signal pathway in lung cancer cells.

Authors:  Mingze Ma; Fengxian Shi; Ruonan Zhai; Hang Wang; Ke Li; Chunyan Xu; Wu Yao; Fang Zhou
Journal:  Mol Biol Rep       Date:  2021-04-01       Impact factor: 2.316

Review 2.  MicroRNA and ROS Crosstalk in Cardiac and Pulmonary Diseases.

Authors:  Montserrat Climent; Giacomo Viggiani; Ya-Wen Chen; Gerald Coulis; Alessandra Castaldi
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

Review 3.  Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression.

Authors:  Lei Zhang; Xiulan Zheng; Wen Cheng; Xuefei Zhang; Lingling Wang; Haixia Li
Journal:  Cell Death Dis       Date:  2020-07-24       Impact factor: 8.469

4.  Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma.

Authors:  Keita Maemura; Kousuke Watanabe; Takahiro Ando; Noriko Hiyama; Toshio Sakatani; Yosuke Amano; Hidenori Kage; Jun Nakajima; Yutaka Yatomi; Takahide Nagase; Daiya Takai
Journal:  Cancer Sci       Date:  2018-09-06       Impact factor: 6.716

5.  The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.

Authors:  Jun Huang; U-Ging Lo; Shiqi Wu; Bin Wang; Rey-Chen Pong; Chih-Ho Lai; Ho Lin; Dalin He; Jer-Tsong Hsieh; Kaijie Wu
Journal:  Cell Death Dis       Date:  2019-06-04       Impact factor: 8.469

6.  Renoprotective effects of brown adipose tissue activation in diabetic mice.

Authors:  Ying-Ying Cai; Hong-Bin Zhang; Cun-Xia Fan; Yan-Mei Zeng; Shao-Zhou Zou; Chun-Yan Wu; Ling Wang; Shu Fang; Ping Li; Yao-Ming Xue; Mei-Ping Guan
Journal:  J Diabetes       Date:  2019-05-30       Impact factor: 4.006

7.  Identifying Potential miRNAs-Disease Associations With Probability Matrix Factorization.

Authors:  Junlin Xu; Lijun Cai; Bo Liao; Wen Zhu; Peng Wang; Yajie Meng; Jidong Lang; Geng Tian; Jialiang Yang
Journal:  Front Genet       Date:  2019-12-11       Impact factor: 4.599

8.  Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study.

Authors:  Yu-Ting Chen; Jian-Ni Yao; Yu-Tao Qin; Kai Hu; Fang Wu; Ye-Ying Fang
Journal:  FEBS Open Bio       Date:  2018-06-26       Impact factor: 2.693

9.  miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer.

Authors:  Andrea Feliciano; Yoelsis Garcia-Mayea; Luz Jubierre; Cristina Mir; Manuela Hummel; Josep Castellvi; Javier Hernández-Losa; Rosanna Paciucci; Irene Sansano; Yilin Sun; Santiago Ramón Y Cajal; Hiroshi Kondon; Aroa Soriano; Miguel Segura; Alex Lyakhovich; Matilde E LLeonart
Journal:  Cell Death Dis       Date:  2017-10-26       Impact factor: 8.469

Review 10.  Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases.

Authors:  Arun Samidurai; Rakesh C Kukreja; Anindita Das
Journal:  Oxid Med Cell Longev       Date:  2018-08-23       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.